Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03070925 · ClinicalTrials.gov registry record
Prospective PuraPly™ AM Case Series Study
A clinical trial of Pressure Ulcers and Venous Ulcers, sponsored by Organogenesis.
- Completed
- Registry status
- 43
- Enrollment target
- 1
- Study location
NCT03070925: Completed study of Pressure Ulcers and Venous Ulcers, sponsored by Organogenesis.
NCT03070925 is a study of Pressure Ulcers and Venous Ulcers that has completed, run by Organogenesis. The registered enrollment target is 43 participants, below the 225-participant average among 5 other Pressure Ulcers trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03070925, a study of Pressure Ulcers and Venous Ulcers, has completed, sponsored by Organogenesis.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
The PuraPly AM case series is a prospective, observational study for patients who have received PuraPly AM which consists of a collagen sheet coated with polyhexamethylene biguanide hydrochloride (PHMB) and is intended for the management of wounds; no experimental intervention is involved.
Primary Outcome
As measured from change in status from baseline
Conditions Studied
Interventions
- DEVICE PuraPly™ Antimicrobial Wound Matrix
Study Locations (1)
New York
- Northwell Health, Inc - Lake Success
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-05 |
What the finished NCT03070925 record still lists
NCT03070925 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 225-participant average among 5 other Pressure Ulcers trials with a reported enrollment target (81% lower).
The record links to 5 conditions, with Pressure Ulcers appearing as the primary indexed condition, and to 1 intervention - of which PuraPly™ Antimicrobial Wound Matrix is the first listed.
NCT03070925 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03070925 about?
NCT03070925 is a clinical study titled "Prospective PuraPly™ AM Case Series Study". The PuraPly AM case series is a prospective, observational study for patients who have received PuraPly AM which consists of a collagen sheet coated with polyhexamethylene biguanide hydrochloride (PHMB) and is intended for the management of wounds; no experimental intervention is involved.
What is the current status of trial NCT03070925?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2016-11. Estimated completion is 2017-05.
What conditions does trial NCT03070925 study?
This clinical trial studies the following conditions: Pressure Ulcers, Venous Ulcers, Diabetic Ulcers, Surgical Wounds, Trauma Wounds.
What interventions are being tested in trial NCT03070925?
The interventions under investigation include: PuraPly™ Antimicrobial Wound Matrix (DEVICE).
Who is sponsoring clinical trial NCT03070925?
This trial is sponsored by Organogenesis, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03070925 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pressure Ulcers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care
RECRUITING · NA
-
Wound Healing Endpoint and Recurrence
ACTIVE NOT RECRUITING · Phase 1
-
Wound Management for Sacral Pressure Ulcers With Necrotic Tissue
COMPLETED · Phase 4
-
Pressure Ulcer Prevention: Turning for Ulcer Reduction
COMPLETED · Phase 3
-
Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia